Takeshi Yusasa

34PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsOrthoptics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Dec 10, 2025
Rethinking evidence standards for men with metastatic prostate cancer in the post-androgen receptor pathway inhibitor setting: new insights from CONTACT-02.

Kosuke Takemura, Takeshi Yusasa

|Jul 03, 2025
An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch Syndrome.

Yuki Shimozawa, Yosuke Yasuda, Emiko Sugawara

|Mar 04, 2025
A case of seminal vesicle metastasis from bilateral seminoma.

Yusuke Aida, Yosuke Yasuda, Emiko Sugawara

|Aug 10, 2024
Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy.

Ryo Fujiwara, Shinya Yamamoto, Kosuke Takemura

|Jan 31, 2024
Editorial comment to Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.

Takeshi Yuasa

|Jan 04, 2024
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy.

Ichiro Yonese, Noboru Numao, Kentaro Inamura

Pageof 6

Frequent Collaborators

8 joint publications

Ryo Fujiwara

6 joint publications

Shinya Yamamoto

4 joint publications

Motohiro Fujiwara

3 joint publications

Yoshinobu Komai